Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

University of Kansas Cancer Center

     
Westwood , KS 66205
USA

 

Principal Investigator:
 Stephen Williamson, MD
Contact:
 Christopher Baierl 913-588-4721 cbaierl@kumc.edu Margaret Hapgood 913-588-2566 mhapgood@kumc.edu
Activation Status of this Site:
 Closed
Notes about this Site:
University of Kansas Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.